Morepen Laboratories LimitedNSE: MOREPENLAB

Press Release Apr 17 2026

· Issued by Morepen Laboratories Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Morepen Laboratories Limited has announced the successful completion of a USFDA inspection at its Masulakhanna facility with no adverse observations, marking the fourth consecutive successful inspection for the company. This achievement highlights Morepen's commitment to quality and regulatory standards, enhancing its credibility with global regulators and customers. The company is also expanding into the CDMO space, leveraging its strong regulatory track record and infrastructure.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Morepen Laboratories Limited on 6ix

Earlier from Morepen Laboratories

Later from Morepen Laboratories

All Morepen Laboratories news releases